Search results (13)
« Back to NewsNew review highlights advances and challenges in studying antigen-specific T cells
24 Jul, 2026
A new review published in Nature Reviews Immunology by Professor Tao Dong's group at the CAMS Oxford Institute and the MRC Translational Immune Discovery Unit highlights recent advances and remaining challenges in studying antigen-specific T cells - rare immune cells that recognise viruses, bacteria, tumours and self-antigens, and play central roles in protective immunity and autoimmune disease.
Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies
25 Jun, 2026
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease
11 Jun, 2026
Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.
Oxford Population Health researchers to tackle one of cancer’s toughest challenges
4 Mar, 2026
Oxford researchers join $25m international effort to uncover immune mechanisms that protect certain people from cancer.
New Oxford-led trial explores if the immune system can be trained to control HIV
6 Feb, 2026
Can the immune system be trained to control HIV without continuous medication? A new Oxford-led clinical trial is exploring whether immune-based strategies could support longer-term viral control after stopping antiretroviral therapy.
Rapamycin helps protect immune cells against DNA damage
26 Jan, 2026
New research carried out by Dr Loren Kell at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has demonstrated for the first time that rapamycin can reduce DNA damage in immune cells, a hallmark of ageing.
Dr Ignacio Melero recognised for global contribution to advances in cancer immunotherapy
9 Nov, 2025
The Society for Immunotherapy of Cancer (SITC) has honoured Dr Ignacio (Nacho) Melero, Professor of Immunotherapy at NDM's Centre for Immuno-Oncology at Oxford, for his pioneering research transforming cancer treatment through immunotherapy.
NDM scientists receive funding for children’s cancer vaccine development
7 Oct, 2025
A new partnership between Alice’s Arc, the Centre for Immuno-Oncology in the Nuffield Department of Medicine and the Sir William Dunn School of Pathology will pioneer the development of a bespoke mRNA vaccine to improve treatment outcomes for children with rhabdomyosarcoma, a rare and aggressive form of soft tissue cancer.
New research finds T cells linked to mild COVID-19 and future protection
2 Oct, 2025
A new study, led by researchers at the CAMS Oxford Institute in the Nuffield Department of Medicine and TIDU in the MRC Weatherall Institute of Molecular Medicine, has found that dominant T cell responses years after infection are associated with mild COVID-19 disease, and likely play important protective roles to following viral infections.
New study to improve vaccines and therapeutics development
1 May, 2024
A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it.
AI-based method provides insights for predicting colorectal cancer outcomes
2 Feb, 2024
The largest multiparameter immunoprofiling study in cancer to date has suggested an underappreciated role of a subset of immune cells in determining the risk of bowel cancer relapse after surgery.
Study uncovers how the Hepatitis B virus adapts
30 Jan, 2024
A new hepatitis B study reveals how viruses adapt to low-oxygen environments, such as those found deep within the liver, opening up possible new therapeutic targets for liver pathogens. NDM researchers have identified hypoxia-inducible factors (HIFs) playing an important role in the regulation of editing of viral RNAs in low oxygen conditions.
UK minister meets with Oxford pandemic researchers
29 Jan, 2024
Researchers at the Jenner Institute, the Oxford Vaccine Group and the Pandemic Sciences Institute hosted the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.